Prophylactic or early therapeutic vaccination with GAds encoding nAgs in mice induced CD8+ and CD4+ T cells and efficiently controlled tumor growth, irrespective of the number of encoded nAgs. The gene discussed is CD8A; the disease is neoplasm.